Cargando…

Impact of health technology assessment on prescribing patterns of inhaled fixed-dose combination triple therapy in chronic obstructive pulmonary disease

Background: Evidence suggests that triple therapy for patients with chronic obstructive pulmonary disease (COPD) is being used in a broader range of patients than recommended by guidelines, which may have health and cost implications. Objective: To explore the relationship between national health te...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cook, Jennifer, Bloom, Chloe, Lewis, Jen, Marjenberg, Zoe, Platz, Jaime Hernando, Langham, Sue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Routledge 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174477/ https://www.ncbi.nlm.nih.gov/pubmed/34122781 http://dx.doi.org/10.1080/20016689.2021.1929757

Ejemplares similares

Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review
por: Langham, Sue, et al.
Publicado: (2019)

Reducing carbon footprint by switching to reusable soft-mist inhalers
por: Janson, Christer, et al.
Publicado: (2023)

The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis
por: Pego-Reigosa, José María, et al.
Publicado: (2020)

A Delphi Consensus Document on the Use of Single-Inhaler Fixed-Dose Triple Therapies in COPD Patients
por: López-Campos, José Luis, et al.
Publicado: (2020)

The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries
por: Lewis, A., et al.
Publicado: (2016)

Prescribing pathways to triple therapy in patients with chronic obstructive pulmonary disease in the United States
por: Schabert, Vernon, et al.
Publicado: (2021)

Prescribing Patterns for Long-Acting Inhaled Bronchodilators Among Rural Adults With Chronic Obstructive Pulmonary Disease
por: Brunner, Wendy M., et al.
Publicado: (2022)

Different inhaled corticosteroid doses in triple therapy for chronic obstructive pulmonary disease: systematic review and Bayesian network meta-analysis
por: Lee, Hyun Woo, et al.
Publicado: (2022)

Fixed Triple Therapy in Chronic Obstructive Pulmonary Disease and Survival. Living Better, Longer, or Both?
por: Vestbo, Jørgen
Publicado: (2020)

Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD
por: D’Urzo, Anthony, et al.
Publicado: (2019)

Outcomes and costs of treating chronic obstructive pulmonary disease with inhaled fixed combinations: the Italian perspective of the PATHOS study
por: Roggeri, Alessandro, et al.
Publicado: (2014)

Modeling of pulmonary deposition of agents of open and fixed dose triple combination therapies through two different low-resistance inhalers in COPD: a pilot study
por: Erdelyi, Tamas, et al.
Publicado: (2023)

Use of single-inhaler triple therapy in the management of obstructive airway disease: Indian medical experts’ review
por: Dhar, Raja, et al.
Publicado: (2022)

Single-inhaler triple vs single-inhaler dual therapy in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized control trials
por: Long, Huanyu, et al.
Publicado: (2021)

Changes in COPD inhaler prescriptions in the United Kingdom, 2000 to 2016
por: Bloom, Chloe I, et al.
Publicado: (2019)

The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials
por: Lai, Chih-Cheng, et al.
Publicado: (2019)

Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline
por: Ferguson, Gary T, et al.
Publicado: (2020)

Patient and Clinical Demographics of New Users to Single-Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease
por: Wu, Benjamin, et al.
Publicado: (2022)

Clinical and Economic Consequences of Inhaled Corticosteroid Doses and Particle Size in Triple Inhalation Therapy for COPD: Real-Life Study
por: Sicras-Mainar, Antoni, et al.
Publicado: (2020)

Assessment of inhalation flow patterns of soft mist inhaler co-prescribed with dry powder inhaler using inspiratory flow meter for multi inhalation devices
por: Hira, Daiki, et al.
Publicado: (2018)

Prescribing Pathways to Triple Therapy: A Retrospective Observational Study of Adults with Chronic Obstructive Pulmonary Disease in the UK
por: Quint, Jennifer K, et al.
Publicado: (2020)

Use and persistence of single and multiple inhaler triple therapy prescribed for patients with COPD in France: a retrospective study on THIN database (OPTI study)
por: Deslee, Gaétan, et al.
Publicado: (2023)

Climate change in healthcare: Exploring the potential role of inhaler prescribing
por: Starup‐Hansen, Joachim, et al.
Publicado: (2020)

The Effects Of Single Inhaler Triple Therapy Vs Single Inhaler Dual Therapy Or Separate Triple Therapy For The Management Of Chronic Obstructive Pulmonary Disease: A Systematic Review And Meta-Analysis Of Randomized Controlled Trials [Corrigendum]
Publicado: (2020)

What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscape
por: Lavorini, Federico, et al.
Publicado: (2019)

Inappropriate prescribing of inhaled corticosteroids: are they being prescribed for respiratory tract infections? A retrospective cohort study
por: Poulos, Leanne M, et al.
Publicado: (2013)

Profile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPD
por: Prakash, Anoop, et al.
Publicado: (2015)

Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region
por: Resta, Emanuela, et al.
Publicado: (2022)

Economic impact of delaying initiation with multiple-inhaler maintenance triple therapy in Spanish patients with chronic obstructive pulmonary disease
por: Sicras Mainar, Antoni, et al.
Publicado: (2019)

Effectiveness of Extrafine Single Inhaler Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) in Germany – The TriOptimize Study
por: Gessner, Christian, et al.
Publicado: (2022)

An evaluation of knowledge, attitude and practices about prescribing fixed dose combinations among resident doctors
por: Goswami, Nimit, et al.
Publicado: (2013)

Cost-effectiveness of the fixed-dose combination tiotropium/olodaterol versus tiotropium monotherapy or a fixed-dose combination of long-acting β2-agonist/inhaled corticosteroid for COPD in Finland, Sweden and the Netherlands: a model-based study
por: Hoogendoorn, Martine, et al.
Publicado: (2021)

Asthma with Fixed Airflow Obstruction: From Fixed to Personalized Approach
por: Bakakos, Agamemnon, et al.
Publicado: (2022)

Current appraisal of single inhaler triple therapy in COPD
por: Lipworth, Brian, et al.
Publicado: (2018)

New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management
por: Singh, Dave, et al.
Publicado: (2022)

Asthma control and COPD symptom burden in patients using fixed-dose combination inhalers (SPRINT study)
por: Roche, Nicolas, et al.
Publicado: (2020)

Treatment patterns and cost of exacerbations in patients with chronic obstructive pulmonary disease using multiple inhaler triple therapy in South Korea
por: Lee, Chang-Hoon, et al.
Publicado: (2022)

Prescribing Pathways to Triple Therapy: A Multi-Country, Retrospective Observational Study of Adult Patients with Chronic Obstructive Pulmonary Disease
por: Quint, Jennifer K., et al.
Publicado: (2020)

Triple fixed drug combinations in type 2 diabetes
por: John, Mathew, et al.
Publicado: (2015)

“Triple-Fix” Arthroscopic Biceps Tenodesis: Indications and Technique
por: Dale, Wood W., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dagv1mjnroqqrhe70cccbd248f